SMARTQCSurgical Outcomes of Retinal Detachment Associated with Proliferative Sickle Cell Retinopathy

Ishrat Ahmed, Taku Wakabayashi, Anthony F Gonzales, Sally S. Ong, Jacob J Light, James T. Handa, Yoshihiro Yonekawa, Adrienne W. Scott
{"title":"SMARTQCSurgical Outcomes of Retinal Detachment Associated with Proliferative Sickle Cell Retinopathy","authors":"Ishrat Ahmed, Taku Wakabayashi, Anthony F Gonzales, Sally S. Ong, Jacob J Light, James T. Handa, Yoshihiro Yonekawa, Adrienne W. Scott","doi":"10.1097/iae.0000000000004145","DOIUrl":null,"url":null,"abstract":"\n \n To evaluate the long-term anatomic and visual outcomes in eyes with sickle cell retinopathy (SCR)-related retinal detachments (RDs).\n \n \n \n Patients who underwent surgery for SCR-related RDs at the Wilmer Eye Institute or Wills Eye Hospital between 2008 and 2020 and followed for at least 6 months post-operatively were retrospectively reviewed. The primary outcome was the rate of single surgery anatomic success (SSAS) and final reattachment.\n \n \n \n This study included 30 eyes from 28 patients (16 female and 12 male) with tractional RD (TRD) (n=13), rhegmatogenous RD (RRD) (n=1), and combined TRD/RRD (n=16). Mean age was 42.1 ± 15.1 years. Mean follow-up duration was 47.8 ± 34.1 months. Twenty-five (83.3%) eyes underwent pars plana vitrectomy (PPV) and 5 (16.7%) eyes underwent PPV with scleral buckle (SB). SSAS was achieved in 21 (70.0%) eyes at 1 year. Final reattachment was achieved in 28 (93.3%) eyes (22 eyes [73.3%] without tamponade). Recurrence of RDs was significantly associated with male gender (P=0.041), absence of previous laser (P= 0.032), iatrogenic breaks (P=0.035), retinectomy (P=0.034), and SO tamponade (OR 7.857, P= 0.024). Overall, the logarithm of the minimum angle of resolution (logMAR) visual acuity improved from 1.53 ± 0.57 (Snellen equivalent, 20/678) to 1.15 ± 1.01 (20/283) at final visit (p = 0.03); however, eyes with recurrent RD did not achieve significant visual improvement.\n \n \n \n PPV to repair SCR-related RDs was effective in achieving anatomic success and improving vision in most eyes. SSAS is critical for optimizing visual outcomes.\n","PeriodicalId":21178,"journal":{"name":"Retina","volume":"28 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/iae.0000000000004145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To evaluate the long-term anatomic and visual outcomes in eyes with sickle cell retinopathy (SCR)-related retinal detachments (RDs). Patients who underwent surgery for SCR-related RDs at the Wilmer Eye Institute or Wills Eye Hospital between 2008 and 2020 and followed for at least 6 months post-operatively were retrospectively reviewed. The primary outcome was the rate of single surgery anatomic success (SSAS) and final reattachment. This study included 30 eyes from 28 patients (16 female and 12 male) with tractional RD (TRD) (n=13), rhegmatogenous RD (RRD) (n=1), and combined TRD/RRD (n=16). Mean age was 42.1 ± 15.1 years. Mean follow-up duration was 47.8 ± 34.1 months. Twenty-five (83.3%) eyes underwent pars plana vitrectomy (PPV) and 5 (16.7%) eyes underwent PPV with scleral buckle (SB). SSAS was achieved in 21 (70.0%) eyes at 1 year. Final reattachment was achieved in 28 (93.3%) eyes (22 eyes [73.3%] without tamponade). Recurrence of RDs was significantly associated with male gender (P=0.041), absence of previous laser (P= 0.032), iatrogenic breaks (P=0.035), retinectomy (P=0.034), and SO tamponade (OR 7.857, P= 0.024). Overall, the logarithm of the minimum angle of resolution (logMAR) visual acuity improved from 1.53 ± 0.57 (Snellen equivalent, 20/678) to 1.15 ± 1.01 (20/283) at final visit (p = 0.03); however, eyes with recurrent RD did not achieve significant visual improvement. PPV to repair SCR-related RDs was effective in achieving anatomic success and improving vision in most eyes. SSAS is critical for optimizing visual outcomes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SMARTQ与增殖性镰状细胞视网膜病变相关的视网膜脱离的手术结果
目的:评估镰状细胞视网膜病变(SCR)相关视网膜脱离(RDs)患者的长期解剖和视觉效果。 我们对 2008 年至 2020 年期间在威尔默眼科研究所或威尔斯眼科医院接受 SCR 相关视网膜脱离手术并在术后随访至少 6 个月的患者进行了回顾性研究。主要结果是单次手术解剖成功率(SSAS)和最终重新接合率。 该研究包括28名患者的30只眼睛(女性16名,男性12名),这些患者分别患有牵引性RD(TRD)(n=13)、流变性RD(RRD)(n=1)和TRD/RRD合并症(n=16)。平均年龄为(42.1 ± 15.1)岁。平均随访时间为(47.8 ± 34.1)个月。25眼(83.3%)接受了玻璃体旁切除术(PPV),5眼(16.7%)接受了带有巩膜扣带(SB)的PPV。21 只(70.0%)眼睛在 1 年后实现了 SSAS。28只(93.3%)眼睛实现了最终重新接合(22只眼睛[73.3%]未发生填塞)。RD复发与男性性别(P=0.041)、既往未接受激光(P= 0.032)、先天性断裂(P=0.035)、网膜切除术(P=0.034)和SO填塞(OR 7.857,P= 0.024)显著相关。总体而言,最小解像角对数(logMAR)视力从最后一次就诊时的 1.53 ± 0.57(斯奈伦等效视力,20/678)提高到 1.15 ± 1.01(20/283)(P=0.03);但是,复发性 RD 眼的视力没有明显改善。 PPV修复SCR相关RD的效果很好,大部分眼睛都获得了解剖学上的成功并改善了视力。SSAS对于优化视觉效果至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
GENETIC ETIOLOGY AND CLINICAL FEATURES OF ACHROMATOPSIA IN JAPAN. IMAGING PREDICTORS OF FUNCTIONAL OUTCOMES AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR. FACTORS ASSOCIATED WITH DELAYED DIAGNOSIS IN PATIENTS WITH PRIMARY VITREORETINAL LYMPHOMA. MICROVASCULAR CHANGES IN TREATMENT-NAÏVE NONEXUDATIVE MACULAR NEOVASCULARIZATION COMPLICATED BY EXUDATION. ORAL CURCUMIN TO REDUCE RISK OF PROLIFERATIVE VITREORETINOPATHY FOLLOWING RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1